PT Merck Tbk (IDX:MERK)

Market Cap	1.57T -2.2%
Revenue (ttm)	1.27T +26.6%
Net Income	295.88B +106.9%
EPS	660.45 +106.9%
Shares Out	448.00M
PE Ratio	5.30
Forward PE	n/a
Dividend	170.00 (4.97%)
Ex-Dividend Date	Jun 8, 2026

Volume	90,500
Open	3,420.00
Previous Close	3,420.00
Day's Range	3,390.00 - 3,590.00
52-Week Range	2,720.00 - 4,500.00
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About PT Merck Tbk

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, mult...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1970
• Employees: 362
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: MERK

Financial Performance

In 2025, PT Merck Tbk's revenue was 1.20 trillion, an increase of 15.81% compared to the previous year's 1.04 trillion. Earnings were 243.90 billion, an increase of 58.93%.